Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9609 - 9616 of 11617 results
Lights Out for a 401(k) Investment Fund? Don't Forget the Blackout Notice Rules
November 2, 2014| Blog| Viewpoint
The EEOC Continues to Challenge Employer Wellness Programs Through Litigation
October 31, 2014| Blog| Viewpoint
The Contraception Coverage Controversy Continues…
October 31, 2014| Blog| Viewpoint
Three Take-Aways from the SEC's Six-Month Report on Administrative Proceedings
October 31, 2014| Blog| Viewpoint
Where Did My Customer Go? Some Pleading Parameters for Tortious Interference
October 30, 2014| Blog| Viewpoint
FDA and the Center for Food Safety Reach Settlement Regarding FDA's GRAS Rule
October 30, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.